31344 Federal Register / Vol. 86, No. 111 / Friday, June 11, 2021 / Notices 

1Handbook for Electronic Filing Procedures: 

https://www.usitc.gov/documents/handbook_on_

filing_procedures.pdf. 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission has received a complaint 

and a submission pursuant to § 210.8(b) 

of the Commission’s Rules of Practice 

and Procedure filed on behalf of Crocs, 

Inc. on June 8, 2021. The complaint 

alleges violations of section 337 of the 

Tariff Act of 1930 (19 U.S.C. 1337) in 

the importation into the United States, 

the sale for importation, and the sale 

within the United States after 

importation of certain casual footwear 

and packaging thereof. The complainant 

names as respondents: Cape Robbin Inc. 

of Pomona, CA; Bijora, Inc., d/b/a Akira 

of Chicago, Il; Carol Wright Enterprise 

LLC of Bloomfield, NJ; Dr. Leonard’s 

Healthcare Corp. of Edison, NJ; Crocsky 

of Austin, TX; Fullbeauty Brands Inc. d/ 

b/a Kingsize of New York, NY; Hawkins 

Footwear, Sports, Military & Dixie Store 

of Brunswick, GA; Hobibear Shoes and 

Clothing Ltd. of Brighton, CO; Hobby 

Lobby Stores, Inc. of Oklahoma City, 

OK; Ink Tee of Los Angeles, CA; La 

Modish Boutique of West Covina, CA; 

Legend Footwear, Inc., d/b/a Wild Diva 

of City of Industry, CA; Loeffler Randall 

Inc. of New York, NY; Maxhouse Rise 

Ltd. of Hong Kong; New Genesis Online 

LLC of Newcastle, WA; PW Shoes, Inc. 

a/k/a P&W of Maspeth, NY; SG 

Footwear Meser Grp. Inc. a/k/a S. 

Goldberg & Co. of Hackensack, NJ; ShoeNami, Inc. of Gretna, LA; Sketchers 

USA, Inc. of Manhattan Beach, CA; Star 

Bay Group Inc. of Hackensack, NJ; Yoki 

Fashion International LLC of New York, 

NY; Quanzhou ZhengDe Network Corp., 

d/b/a Amoji of China; 718Closeouts of 

Brooklyn, NY; Royal Deluxe 

Accessories, LLC of New Providence, 

NJ; and Fujian Huayuan Well Import 

and Export Trade Co., Ltd. of China. The 

complainant requests that the 

Commission issue a general exclusion 

order, or in the alternative a limited 

exclusion order, and cease and desist 

orders. 

Proposed respondents, other 

interested parties, and members of the 

public are invited to file comments on 

any public interest issues raised by the 

complaint or § 210.8(b) filing. 

Comments should address whether 

issuance of the relief specifically 

requested by the complainant in this 

investigation would affect the public 

health and welfare in the United States, 

competitive conditions in the United 

States economy, the production of like 

or directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the requested 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the requested remedial 

orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or third 

party suppliers have the capacity to 

replace the volume of articles 

potentially subject to the requested 

exclusion order and/or a cease and 

desist order within a commercially 

reasonable time; and 

(v) explain how the requested 

remedial orders would impact United 

States consumers. 

Written submissions on the public 

interest must be filed no later than by 

close of business, eight calendar days 

after the date of publication of this 

notice in the Federal Register. There 

will be further opportunities for 

comment on the public interest after the 

issuance of any final initial 

determination in this investigation. Any 

written submissions on other issues 

must also be filed by no later than the 

close of business, eight calendar days 

after publication of this notice in the 

Federal Register. Complainant may file 

replies to any written submissions no 

later than three calendar days after the 

date on which any initial submissions 

were due. No other submissions will be 

accepted, unless requested by the 

Commission. Any submissions and 

replies filed in response to this Notice 

are limited to five (5) pages in length, 

inclusive of attachments. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. Submissions should refer 

to the docket number (‘‘Docket No. 

3551’’) in a prominent place on the 

cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, Electronic Filing 

Procedures 1). Please note the 

Secretary’s Office will accept only 

electronic filings during this time. 

Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. Persons with questions 

regarding filing should contact the 

Secretary at EDIS3Help@usitc.gov. 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: June 8, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–12310 Filed 6–10–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–848] 

Importer of Controlled Substances 

Application: Adiramedica, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 111 / Friday, June 11, 2021 / Notices 31345 

SUMMARY: Adiramedica, LLC. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 12, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 17, 2021, 

Adiramedica, LLC., 585 Turner 

Industrial Way, Aston, Pennsylvania 

19014, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug code Schedule 

Tapentadol ........................ 9780 II 

The company plans to import 

Tapentadol (9780) in dosage form for 

clinical trials. No other activity for this 

drug code is authorized for this 

registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12290 Filed 6–10–21; 8:45 am] 

BILLING CODE P 

NATIONAL ARCHIVES AND RECORDS 

ADMINISTRATION 

[NARA–2021–026] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: National Archives and Records 

Administration (NARA). 

ACTION: Notice of proposed extension 

request. 

SUMMARY: We are proposing to request 

an extension from the Office of 

Management and Budget (OMB) of a 

currently approved information 

collection, ‘‘Use of NARA Official Seals 

and Logos.’’ Members of the public and 

other Federal agencies provide 

information under this collection as part 

of their requests to use our official 

seal(s) and logo(s). We invite you to 

comment on this proposed information 

collection pursuant to the Paperwork 

Reduction Act of 1995. 

DATES: We must receive written 

comments on or before August 10, 2021. 

ADDRESSES: Send comments by email to 

tamee.fechhelm@nara.gov. Because our 

buildings are temporarily closed during 

the COVID–19 restrictions, we are not 

able to receive comments by mail during 

this time. 

FOR FURTHER INFORMATION CONTACT: 

Tamee Fechhelm, Paperwork Reduction 

Act Officer, by email at 

tamee.fechhelm@nara.gov or by 

telephone at 301.837.1694 with requests 

for additional information or copies of 

the proposed information collection and 

supporting statement. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Paperwork Reduction Act of 1995 

(Pub. L. 104–13), we invite the public 

and other Federal agencies to comment 

on proposed information collections. If 

you have comments or suggestions, they 

should address one or more of the 

following points: (a) Whether the 

proposed information collection is 

necessary for NARA to properly perform 

its functions; (b) our estimate of the 

burden of the proposed information 

collection and its accuracy; (c) ways we 

could enhance the quality, utility, and 

clarity of the information we collect; (d) 

ways we could minimize the burden on 

respondents of collecting the 

information, including through 

information technology; and (e) whether 

this collection affects small businesses. 

We will summarize any comments 

you submit and include the summary in 

our request for OMB approval. All 

comments will become a matter of 

public record. 

In this notice, we solicit comments 

concerning the following information 

collection: 

Title: Use of NARA Official Seals and 

Logos. 

OMB number: 3095–0052. 

Agency form number: N/A. 

Type of review: Regular. 

Affected public: Business or other forprofit, not-for-profit institutions, Federal 

Government. 

Estimated number of respondents: 37. 

Estimated time per response: 15 

minutes. 

Frequency of response: On occasion. 

Estimated total annual burden hours: 

9 hours. 

Abstract: The authority for this 

information collection is contained in 

36 CFR 1200.8. NARA’s three official 

seals are the National Archives and 

Records Administration seal; the 

National Archives seal; and the 

Nationals Archives Trust Fund Board 

seal. The official seals are used to 

authenticate various copies of official 

records in our custody and for other 

official NARA business. We also have 

an official NARA logo, and other official 

program and office logos (such as the 

Federal Register logo, Presidential 

library logos, Controlled Unclassified 

Information logo, National Historical 

Publications and Records Center logo, 

and more). Occasionally, when criteria 

are met, we will permit the public or 

other Federal agencies to use our official 

seals and logos. The requestor must 

submit a written request, that includes 

certain information outlined in 36 CFR 

1200, to use the official seals and logos. 

We approve or deny the request using 

specific criteria, also outlined in the 

regulation. 

Swarnali Haldar, 

Executive for Information Services/CIO. 

[FR Doc. 2021–12268 Filed 6–10–21; 8:45 am] 

BILLING CODE 7515–01–P 

NATIONAL FOUNDATION ON THE 

ARTS AND THE HUMANITIES 

National Endowment for the Arts 

National Council on the Arts 203rd 

Meeting 

AGENCY: National Endowment for the 

Arts, National Foundation on the Arts 

and the Humanities. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to section 10(a)(2) of 

the Federal Advisory Committee Act, as 

amended, notice is hereby given that a 

meeting of the National Council on the 

Arts will be held open to the public by 

videoconference or teleconference. 


jbell on DSKJLSW7X2PROD with NOTICES